Implementing Best Practice in the Management of Atrial Fibrillation-Related Stroke Prevention: Improving Outcomes, Accelerating Progress

16 September 2016 Institute of Translational Medicine, Heritage Building (Queen Elizabeth Hospital), Mindelsohn Way, Birmingham B15 2TH

This panel-led policy meeting has been initiated, organised and funded by the Bristol-Myers Squibb-Pfizer Alliance and is supported by the West Midlands Academic Health Science Network. It will provide an opportunity to examine what more could be done to ensure best practice in the management of AF-related stroke prevention is implemented across Birmingham and the West Midlands.

The meeting will be chaired by the Rt Hon Lord Hunt of Kings Heath OBE, Opposition Spokesperson for Health and former Chairman of the Heart of England NHS Foundation Trust. Panellists will include:

  • Professor David Fitzmaurice, Clinical Lead for Primary Care Clinical Sciences, University of Birmingham
  • Dr Yassir Javaid, CVD Lead and Clinical Champion, East Midlands Strategic Clinical Network
  • Dawn Jevons, Relationship Manager, and Laura Harris, Senior Prevention Marketing Officer at the Stroke Association
  • Dr Christopher Parker CBE, Managing Director, West Midlands Academic Health Science Network.

The outcomes of the meeting will feed into a report of the meeting, which will capture the main discussion points on what actions can be taken to help embed best practice in the prevention of AF-related stroke in Birmingham and the West Midlands. All comments will be anonymised for the report and it will be circulated to key policy-makers and stakeholders both locally and nationally. All attendees will be asked to declare any interests in writing for inclusion in the post-meeting report

Registration

This meeting on 16 September is for the following audiences only to attend:

  • Healthcare professionals
  • Policy makers
  • Healthcare commissioners
  • Public health representatives
  • Patient group representatives.

Delegates must apply to attend by contacting Rebecca Godfrey at rebecca.godfrey@weareicg.com or on 0207 824 1862 by Friday 11 September 2016. Please do not arrive without applying, as you will be turned away on the day if you have not formally registered.                

By providing your personal information, you agree that the information will be held on a database (located within or outside the EU) controlled by Pfizer Limited and used for the purpose of meeting registration and contacting you about similar events in the future. Only the BMS-Pfizer Alliance, organisations working with the BMS-Pfizer Alliance in the administration of your information, and BMS-Pfizer Alliance group companies will have access to your information. We will always employ appropriate technical security measures to protect your personal information and to ensure that it is not access by unauthorised persons. You will at any time have the right to access your information, you can request that your information on the BMS-Pfizer database is amended, or you can unsubscribe from any programme at any time by emailing us at: DataProtectionUK@Pfizer.com.

ICG (Insight Consulting Group) sometimes processes personal information to enable us to promote our goods and services, to maintain our accounts and records and to support and manage our staff. ICG takes seriously its obligations to protect and safeguard personal and business information. To this end, ICG has a standing Information Security Policy (ISP) that has been approved by all Directors at ICG. Information is protected in line with all relevant ICG policies and legislation (notably those relating to data protection and human rights).

To contact Pfizer for any other purpose, including adverse event reports or medical information requests, please call 01304 616161.